STEVEN BUSSELEN: Open Payments
NPI 1689787202 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 38 payments from 12 companies in 2025. Trend: 2023 $637 · 2024 $511 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $269 |
| Indivior Inc. | 7 | $175 |
| ViiV Healthcare Company | 4 | $99 |
| SANOFI-AVENTIS U.S. LLC | 3 | $61 |
| Exact Sciences Corporation | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Alkermes, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: SUBLOCADE, APRETUDE, TZIELD, Cologuard Collection Kit, PREVNAR 20, VIVITROL, MOUNJARO, Ozempic.
Industry payments across CA — which companies pay providers there.
